UFC women’s bantamweight fighter Ashlee Evans-Smith has been saddled with a 14-month suspension by USADA, following a pair of positive drug tests earlier this year.
Evans-Smith (6-5), who has not competed since a November 2020 loss to Norma Dumont, tested positive in January for “an anabolic androgenic steroid of exogenous origin,” per a press release issued Monday. According to USADA (U.S. Anti-Doping Agency) officials, the 34-year old declared use of dehydroepiandrosterone (DHEA) on the paperwork she submitted in conjunction with the drug test samples she provided on January 3 and January 27, 2022.
While initially looking at a stiffer sanction, Evans-Smith will instead serve 14 months, dating back to January 3, 2022. “During an investigation into the circumstances of the case, Evans-Smith provided evidence, including medical records, indicating that a physician incorrectly prescribed DHEA to her,” Monday’s press release stated. “As such, USADA determined that Evans-Smith’s degree of fault was diminished and that she should receive a reduced period of ineligibility. She also received a reduction for her Full and Complete Cooperation.”
In 2015, Evans-Smith was suspended for nine months after failing a post-fight drug test, for use of a diuretic. She was also fined 30% of her purse from a loss against Raquel Pennington at UFC 181.
Currently, Ashlee Evans-Smith does not have any fights announced, and has not been part of any reported match-ups since the loss to Dumont. Her last win came in 2018 when she captured a unanimous decision against Bec Rawlings in a flyweight bout. Of late, she has been promoting her own OnlyFans style website, AshleeRebelGirl.
